Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
Gestodene IUS
Product Overview
Alternative Name:
GES IUD
Development Status:
Active Development
Target:
Female
Mode:
Hormonal
Delivery Type:
Intrauterine
Duration Type:
Long-acting
Description:
An intrauterine system (IUS) that releases gestodene, a progestin used in oral contraceptives available in Europe, but which is not approved in any product marketed in the U.S.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
gestodene
Inactive material:
Silicon rubber
Potential Multi-Purpose Technology (MPT):
No
Duration:
5 years
Dose:
52 mg
Partner:
Shanghai Institute of Planned Parenthood Research (SIPPR)
Status
Project Phase:
Early Development
Project Stage:
Lead Optimization
Began discovery in:
2007
Status Details:
SIPPR is conducting in vitro studies on release rates of gestodene from an intrauterine reservoir.
Programmatic Considerations
Additional Information
Download Product Report
